ArticleSurgical endoscopy2026
Minimally invasive hepatectomy in ambulatory surgery: a retrospective study on prospectively collected data in a consecutive patient cohort.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmbulatory surgery effectively optimizes the allocation of medical resources and reduces patients' hospitalization time and related costs. Minimally invasive hepatectomy in ambulatory surgery (MIHAS) is rarely reported due to complexity of perioperative management and technical challenges. This study aimed to evaluate safety and feasibility of MIHAS.
methodsThe demographics and short-term outcomes of a consecutive series of patients who underwent MIHAS between July 01, 2024, and January 01, 2025, were analyzed.
resultsThirty-four patients (26 males and eight females, mean age, 56 years). Ten patients underwent left lateral hepatectomy, 19 underwent segmentectomy, and five underwent wedge hepatectomy. All MIHAS procedures were successfully performed without conversion to open surgery. The median operative time was 105 (89.5, 121.5) min, and median estimated blood loss was 35 (20, 50) ml. No patient required a blood transfusion. No patient experienced major postoperative complications (Clavien-Dindo grade ≥ III), post-hepatectomy liver failure, postoperative bile leakage, post-hepatectomy hemorrhage. No patient required reoperation or readmission to the hospital, and no 30-day mortality was observed.
conclusionMIHAS can be safely and feasibly implemented in high-volume minimally invasive teams in selected patients. Further research and more surgical experience are needed to determine the indications for MIHAS.
Indexed as
Identifiers
41361511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.